Last reviewed · How we verify

NCT04499092: COREABI

COgnitive REhabilitation in Pediatric Patients with ABI, from Vegetative State to Functional Recovery

Completed NA Last updated 13 December 2024
What this trial tests

NA trial testing Personalized Neuropsychological treatment (CORE-ABI) in Acquired Brain Injury in 184 participants. Completed in 31 December 2023.

Timeline
1 October 2019
Primary endpoint
28 February 2022
31 December 2023

Quick facts

Lead sponsorIRCCS Eugenio Medea
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment184
Start date1 October 2019
Primary completion28 February 2022
Estimated completion31 December 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS Eugenio Medea — full company profile →

Who can join

Adults 3 Months to 17, any sex, with Acquired Brain Injury or Development, Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acquired brain injuries (ABI) represent one of the most important cause of disability and mortality during the pediatric age, also in the western Countries. The important medical progress of the last decade has increased the percentages of survivals, also in patients with the most severe clinical pictures. On the other hand, a brain injury reported in the first years of life presents with a more dramatic impact on cognitive and neurological development of patients and it may significantly interfere with adjustment, vocational perspectives and quality of life. Recent studies suggest that a brain damage at an early stage of development is related to more persistent sequelae in comparison with a comparable lesion reported by an adult patient, because of the neurological immaturity of the central nervous system at the moment of the insult. Furthermore, in most cases, a brain injury is related not only to motor and sensory deficits but also to significant behavioral and cognitive problems, that may occur immediately after the acute phase and persist or worsen over the years.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Neuropsychological assessment through Coma Recovery Scale-Revised and Coma/Near Coma Scale in a sample of pediatric patients with disorder of consciousness.
    Frigerio S, Molteni E, Colombo K, Pastore V, et al · · 2023 · cited 12× · PMID 36335241 · DOI 10.1007/s00415-022-11456-6
  2. Randomized clinical trial on the effects of early cognitive interventions for children with acquired brain injury.
    Corti C, Frigerio S, Recla M, Galbiati S, et al · · 2025 · PMID 40596349 · DOI 10.1038/s41598-025-06793-1

Verify or expand the search:

Other recruiting trials for Acquired Brain Injury

Currently open trials in the same condition.

Other IRCCS Eugenio Medea trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04499092.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing